P
Provention Bio Inc
F:2VB
Provention Bio Inc
F:2VB
Price:
21.6
EUR
-0.46%
Market Closed
Market Cap:
€2B
Cash Flow Statement
Cash Flow Statement
Provention Bio Inc
Provention Bio Inc
Currency: USD
| Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(9)
|
(14)
|
(20)
|
(24)
|
(26)
|
(32)
|
(34)
|
(38)
|
(43)
|
(45)
|
(55)
|
(77)
|
(99)
|
(118)
|
(125)
|
(121)
|
(114)
|
(104)
|
(105)
|
(106)
|
(114)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
4
|
4
|
5
|
6
|
6
|
6
|
2
|
2
|
3
|
4
|
5
|
7
|
14
|
15
|
17
|
18
|
12
|
13
|
13
|
13
|
19
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Change in Working Capital |
1
|
(1)
|
0
|
(1)
|
(2)
|
3
|
4
|
4
|
4
|
3
|
5
|
9
|
9
|
19
|
12
|
7
|
6
|
(3)
|
(1)
|
2
|
18
|
|
| Cash from Operating Activities |
(5)
N/A
|
(11)
-123%
|
(15)
-40%
|
(20)
-32%
|
(23)
-13%
|
(24)
-6%
|
(29)
-21%
|
(32)
-11%
|
(36)
-12%
|
(38)
-5%
|
(46)
-21%
|
(61)
-34%
|
(76)
-24%
|
(84)
-10%
|
(96)
-15%
|
(97)
-1%
|
(95)
+1%
|
(94)
+2%
|
(92)
+2%
|
(91)
+1%
|
(75)
+17%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(46)
|
(39)
|
(26)
|
(29)
|
26
|
12
|
1
|
16
|
(30)
|
(13)
|
(15)
|
(74)
|
(87)
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(46)
N/A
|
(39)
+15%
|
(26)
+33%
|
(29)
-11%
|
25
N/A
|
10
-59%
|
(1)
N/A
|
15
N/A
|
(31)
N/A
|
(14)
+56%
|
(15)
-13%
|
(75)
-384%
|
(88)
-18%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
27
|
0
|
0
|
59
|
59
|
0
|
59
|
63
|
63
|
63
|
177
|
114
|
114
|
216
|
103
|
103
|
102
|
2
|
14
|
105
|
106
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
24
|
|
| Other |
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
27
N/A
|
0
N/A
|
(1)
N/A
|
59
N/A
|
59
+0%
|
0
N/A
|
60
N/A
|
63
+5%
|
63
+0%
|
63
+0%
|
177
+180%
|
114
-35%
|
114
+0%
|
216
+89%
|
103
-52%
|
103
0%
|
102
0%
|
2
-98%
|
14
+542%
|
128
+832%
|
129
+1%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
22
N/A
|
16
-27%
|
(16)
N/A
|
39
N/A
|
37
-7%
|
35
-4%
|
31
-12%
|
31
-1%
|
(19)
N/A
|
(14)
+27%
|
105
N/A
|
23
-78%
|
63
+170%
|
143
+127%
|
6
-96%
|
21
+255%
|
(24)
N/A
|
(105)
-337%
|
(94)
+11%
|
(37)
+61%
|
(34)
+8%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(11)
-123%
|
(15)
-40%
|
(20)
-32%
|
(23)
-13%
|
(24)
-6%
|
(29)
-21%
|
(32)
-11%
|
(36)
-12%
|
(38)
-5%
|
(46)
-21%
|
(62)
-35%
|
(77)
-25%
|
(85)
-10%
|
(98)
-15%
|
(98)
0%
|
(96)
+2%
|
(95)
+2%
|
(93)
+2%
|
(91)
+1%
|
(76)
+17%
|
|
Switch to:
Switch to:
See Also
Discover More
